Skip to content
  • Wednesday, 15 April 2026
  • 10:21 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Teva Pharmaceutical Secures FDA Approval for Ponlimsi Biosimilar to Prolia, Advances Xolair Biosimilar Applications in US and EU
Pharmaceutical R&D

Teva Pharmaceutical Secures FDA Approval for Ponlimsi Biosimilar to Prolia, Advances Xolair Biosimilar Applications in US and EU

Teuku Ryan Apr 1, 2026 0

Teva Pharmaceutical has announced a significant milestone in its biosimilar portfolio with the U.S. Food and Drug Administration (FDA) granting…

Read More
Drexel University Researchers Engineer High-Conductivity One-Dimensional MXene Nanoscrolls for Advanced Energy and Quantum ApplicationsChalmers University of Technology Researchers Unveil Giant Superatoms as a Breakthrough Framework for Scalable and Stable Quantum Computing SystemsScripps Research Scientists Develop Novel Blood Test for Alzheimer’s Disease Based on Protein Structural ChangesNovo Nordisk’s new weight loss treatment inferior to Lilly’s tirzepatide
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityLLMOps in 2026: The 10 Tools Every Team Must HaveWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Breakthrough in Male Contraception: Cornell Scientists Identify Nonhormonal Pathway to Reversible Infertility via Meiotic InterruptionThe Quest for Monoclonality: Sartorius Infographic Illuminates Next-Generation Solutions for Cell-Line DevelopmentImmuto Scientific Pioneers AI-Enhanced Mass Spectrometry for Unprecedented Protein Structure ThroughputMental Sharpness and Daily Productivity Gains Quantified in New University of Toronto Study
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Breakthrough in Male Contraception: Cornell Scientists Identify Nonhormonal Pathway to Reversible Infertility via Meiotic Interruption
Dwi Wanna Apr 15, 2026
Biotech & Genetic Research
The Quest for Monoclonality: Sartorius Infographic Illuminates Next-Generation Solutions for Cell-Line Development
Jia Lissa Apr 15, 2026
Laboratory Automation & Robotics
Immuto Scientific Pioneers AI-Enhanced Mass Spectrometry for Unprecedented Protein Structure Throughput
Lana Keisha Apr 15, 2026
Neuroscience & Brain Research
Mental Sharpness and Daily Productivity Gains Quantified in New University of Toronto Study
Rifan Muazin Apr 15, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ